Abstract:Inactivation of tumor suppressor p53 is one of the most frequent events in cancer. Unlike many other cancers, however, p53 gene mutations are infrequent in breast cancers, as about 80% of breast tumors contain wild type p53. The mechanisms underlying functional inactivation of wild type p53 in breast cancer have remained elusive. Besides, how p53 gets activated in breast tumors subjected to radiation therapy remains unknown. We recently reported that in MCF-7 breast cancer cells, estrogen receptor alpha (ERα) directly binds to p53 and represses its function. Furthermore, the ERα-p53 interaction was disrupted by ionizing radiation. These observations have important translational implications especially as there are no reliable cellular or molecular criteria for rational radiotherapy for breast cancer. Here we report our studies towards addressing this important issue, using an MCF-7 breast cancer xenograft model in mice. Radiation effectively inhibits growth of these tumors and stabilizes p53, but has no observable effect on ERα protein level. Importantly, chromatin immunoprecipitation (ChIP) assays demonstrated that ERα interacts with p53 bound to endogenous target gene promoters in tumors in vivo, and this interaction is considerably reduced in response to radiotherapy although p53 level is increased. Concomitant with its effect on ERα-p53 interaction, radiation increases p53-mediated transcriptional activation of several target genes and increases p53-mediated transcriptional repression of survivin. Our studies show that disruption of ERα-p53 interaction in vivo resulting in restoration of functional p53 is a cellular response to radiation. Radiation could be affecting ERα and/or p53 directly or it could be influencing other proteins associated with the ERα-p53 complex. To the best of our knowledge, this is the first report on analysis of DNA–protein–protein interaction occurring on endogenous gene promoters in vivo in breast tumor tissues. These findings suggest that alleviating the inhibitory effect of ERα on p53 could be one of the molecular mechanisms underlying activation of p53 by radiation in breast tumors, and therefore, could be exploited to develop more effective ways of combining radiation therapy with systemic therapies such as hormonal therapy and chemotherapy.

P53, a Target of Estrogen Receptor (ER) Α, Modulates DNA Damage-induced Growth Suppression in ER-positive Breast Cancer Cells

Abstract 1284: Estrogen Receptor Alpha Transcriptionally Regulates P53 in MCF7 Human Breast Cancer Cells

Transcriptional Regulation of Estrogen Receptor-Alpha by P53 in Human Breast Cancer Cells

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

P53 Genotype As a Determinant of ER Expression and Tamoxifen Response in the MMTV-Wnt-1 Model of Mammary Carcinogenesis.

Estrogen Receptor (ER) Β or P53 Attenuates ERα-mediated Transcriptional Activation on the BRCA2 Promoter*

Estrogen Receptor Α Mediates Proliferation of Breast Cancer MCF–7 Cells Via a P21/pcna/e2f1‐dependent Pathway

Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy

Estrogen Receptor β1 Induces Apoptosis of Breast Cancer by Upregulating Expression of p53 Gene

Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer

Differential gene expression in cells with different p53 mutations identifies genome-wide p53 targets and shows distinct modulation of cellular pathways in response to DNA damage

Downregulation of Wild-Type P53 Protein by HER-2/neu Mediated PI3K Pathway Activation in Human Breast Cancer Cells: Its Effect on Cell Proliferation and Implication for Therapy

Estrogen Receptor-α36 is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in in Vitro and in Vivo Breast Cancer

Data from the G Protein–Coupled Receptor 87 is Necessary for P53-Dependent Cell Survival in Response to Genotoxic Stress

Estrogen Promotes Estrogen Receptor Negative BRCA1-deficient Tumor Initiation and Progression.

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression

Expression of P53 in Breast Cancer and Regulatory Effects of 5-Aza-2′-deoxycytidine on P53

CDK11 P58 Inhibits ERα-positive Breast Cancer Invasion by Targeting Integrin Β3 Via the Repression of ERα Signaling